A machine learning-led revolution is underway. It is changing the way we communicate, work, shop and drive. Machine learning is also revolutionising medicine, altering forever the way we understand, build evidence on, and are able to respond to, health problems.
An international clinical trial involving Adelaide researchers has demonstrated the safety and efficacy of a next-generation treatment for people with chronic myeloid leukaemia (CML).
Improving human health is the aim of $11.6 million in new research awarded to the University of Adelaide today, including a major project to investigate tackling two serious infections with one vaccine.